On November 9, 2026 Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, reported that Athena Countouriotis, M.D., Chair, President and CEO, will present and host investor meetings at the 2026 Jefferies Global Healthcare Conference in London, taking place November 16-19, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Jefferies Global Healthcare Conference in London
Event: Corporate Presentation
Date: Wednesday, November 18, 2026
Presentation Time: 4:00 to 4:25 p.m. GMT / 11:00 to 11:25 a.m. EST

A live webcast of the presentation will be accessible on the company’s website, www.avenzotx.com under the Events & Presentations section and an archived recording will be available on the website for 90 days following the presentation.

(Press release, Avenzo Therapeutics, NOV 9, 2026, View Source [SID1234674495])